{"id":121,"date":"2020-09-25T21:22:51","date_gmt":"2020-09-25T21:22:51","guid":{"rendered":"https:\/\/www.joinnbio.com\/?page_id=121"},"modified":"2021-03-01T20:02:48","modified_gmt":"2021-03-01T20:02:48","slug":"resources","status":"publish","type":"page","link":"https:\/\/www.joinnbio.com\/resources\/","title":{"rendered":"Resources"},"content":{"rendered":"\n
\n
\n
\n\n
\n

\n
fig. 1 \u2014<\/span><\/div>\n JOINN Biologics<\/span>\n <\/h3>\n\n

\n News <\/h2>\n <\/div>\n\n<\/div>\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n\n\n
\n\n \n
\n \n
\n\n \n
\n \"\" <\/div>\n\n \n
\n

Join hands with professional investors to build a leading company in the pharmaceutical CDMO field<\/h3>\n
Ziqiang Zeng, Managing partner at Huagai Capital Medical Fund<\/div>\n <\/div>\n \n \"Read\n <\/div>\n <\/a>\n <\/div>\n\n \n
\n \n
\n\n \n
\n \"\" <\/div>\n\n \n
\n

International services to achieve dual registration in China and the US<\/h3>\n
As a domestic CDMO service provider with a CGMP production site in…<\/div>\n <\/div>\n \n \"Read\n <\/div>\n <\/a>\n <\/div>\n\n \n
\n \n
\n\n \n
\n \"sartious\" <\/div>\n\n \n
\n

Provide cell lines with intellectual property to alleviate industry bottlenecks<\/h3>\n
Facing the increasingly strict environment for the regulatory approval of new drugs,…<\/div>\n <\/div>\n \n \"Read\n <\/div>\n <\/a>\n <\/div>\n\n \n
\n \n
\n\n \n
\n \"gene <\/div>\n\n \n
\n

Leverage JOINN brand advantages to provide one-stop service for the biopharmaceutical industry<\/h3>\n
By leveraging JOINN Labs brand and customer resources, JOINN Bio provides comprehensive…<\/div>\n <\/div>\n \n \"Read\n <\/div>\n <\/a>\n <\/div>\n\n \n <\/div>\n\n<\/div>\n\n\n
\n
View More<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n\n
\n

\n
fig. 2 \u2014<\/span><\/div>\n JOINN Biologics<\/span>\n <\/h3>\n\n

\n Public Relations <\/h2>\n <\/div>\n\n<\/div>\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n\n\n
\n\n \n
\n \n
\n\n \n
\n

Case Study for Developability Assessment of Three Therapeutic Antibodies<\/h3>\n
April 1, 2019<\/div>\n
antibody therapeutics, bioinformatics, developability assessment, protein analytics, protein stability, protein heterogeneity, antibody manufacturing<\/div>\n <\/div>\n \n <\/div>\n <\/a>\n <\/div>\n\n \n <\/div>\n\n<\/div>\n\n\n
\n
View More<\/a><\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"_links":{"self":[{"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/pages\/121"}],"collection":[{"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/comments?post=121"}],"version-history":[{"count":15,"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/pages\/121\/revisions"}],"predecessor-version":[{"id":994,"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/pages\/121\/revisions\/994"}],"wp:attachment":[{"href":"https:\/\/www.joinnbio.com\/wp-json\/wp\/v2\/media?parent=121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}